We would love to hear your thoughts about our site and services, please take our survey here.
People saying this would drop if no 7am RNS
I didn't really expect it this morning but wouldn't have been surprised.
It may well be during the day if the news is received at say 5am UK time
HXXps://www.proactiveinvestors.co.uk/companies/news/1040013/kromek-group-s-positive-trajectory-insights-from-ceo-arnab-basu-icymi-1040013.html
....
Stephen Gunnion (SG): Arnab, Kromek's interim results indicate a strong first half with notable financial improvements. Can you elaborate on these achievements?
Arnab Basu (AB): Absolutely, Stephen. We've experienced a period of positive momentum, underpinned by a significant improvement in our EBITDA position and reduced pre-tax losses.
This success stems from our unwavering focus on profitability, achieved through diligent cost control and enhancing our business margins. Our growth has been particularly robust in the advanced imaging and CBRN segments, reflecting our alignment with market demands and our strategic initiatives in these areas.
SG: Could you dive deeper into the growth drivers within your main business segments?
AB: Certainly. Our advanced imaging segment, especially in SPECT and CT modalities, has seen increasing adoption of our CZT material, revolutionizing digital spectrums and enhancing diagnostic capabilities. This trend is underscored by new product launches and significant partnerships, such as our collaboration with a CT Original Equipment Manufacturer (OEM) and Spectrum Dynamics' launch of a new product.
On the CBRN front, global security concerns have spiked demand for our handheld radiation detection tools. Our contract wins and robust pipelines in this segment, alongside partnerships for biosecurity projects with the US and UK governments, mark our strategic advancements and readiness to meet evolving market needs.
SG: With the momentum built in the first half, how do you anticipate this will impact Kromek's performance moving into the full year 2024?
AB: The trajectory we've set in the first half is expected to continue, with the second half traditionally being stronger for us. We're on track to achieve record revenues, a testament to our growth strategy's effectiveness.
Our focus remains on cost control and margin improvement, positioning us to report not only significant revenue growth but also a positive EBITDA for the year. This marks a pivotal step towards our long-term profitability and underscores our commitment to delivering value.
So some still want to buy, suggests there's more to this than we are being led to believe
#uog 86 feet net oil pay “significantly above expectations” . The oil is being tapped on immediately . Plus the most anticipated well of the year, the exploration well ASV-1X well which was originally scheduled for Q4 is now spudding in a few weeks
I soold out a while back, 16th April.
It's good to see this on the rise again and still rising.
I wonder what's going on? There will be sellers all the way unless there's some solid news, though it's tempting to dip back in here.
Just watched this again, time to look down the back of the couch. WOW
https://twitter.com/StockBoxMedia/status/1467897136033501191
Richard Conroy
"The company have reached a milestone moment in the JV deal for Project Inis"
hTTps://twitter.com/StockBoxMedia/status/1467897136033501191
"Dutch health authorities have said on Saturday that 61 passengers from two flights from South Africa tested positive for Covid-19 "
I'm going to hazard a guess that it's omicron.
This suggests to me that it's much more contagious than Delta.
I mean 10% of the two flights infected.
Novacyt Group
@NovacytGroup
·
33m
We can confirm, all our primary #COVID19 assays, targeting ORF1ab, S, M and nsp16 genes will detect the B.1.1.529 #variant. We remain dedicated and at the forefront in our response to the constantly changing global pandemic. #Novacyt #NCYT
"#UOG "Our cash collections have been excellent in Egypt, so we are building up a stronger balance sheet. We are putting together a nice war chest of capital, & given that we have got strong performing assets, I think we are very well placed to take advantage of the market.""
That's right EarlOfAim.
Current and Emerging economies will continue to need O&G for many years. Look at Europe and the UK right now under Putin's thumb. LNG imports will need to come from elsewhere. Oil is now b eing considered as an alternative to gas.
Add into the mix the pressures on majors to appear green. ... fast climbing prices and lots of opportunities, the perfect scenario for smaller companies. Brent crude will be $100 per barrel soon.
Chris Yates, Chief Executive Officer of Abingdon Health, commented: "The launch of the semi-quantitative accessory to AbC-19™ is an important addition to the tools available to researchers as they qualify and measure the antibody level appropriate to infer protective immunity. There is a lot of work underway internationally to set a globally recognised standard threshold and we welcome the establishment of an international standard that will help governments manage their vaccine and booster programmes. Devices such as the AbC-19™ help democratise testing and allow individuals to know their own neutralising antibody status, assess their own risk, and seek appropriate advice when indicated."